Quidel Corporation (QDEL) - Product Pipeline Analysis, 2016 Update

Summary

Summary

Quidel Corporation (Quidel) develops, manufactures and markets rapid diagnostic testing solutions that find applications in infectious diseases, gastrointestinal diseases and women’s health. The company offers cell line products; diagnostic immunoassays including visually read rapid lateral flow tests, ELISAs and fluorescent immunoassays; and others. It offers diagnostic and research assays and reagents in oncology, bone health and inflammatory diseases. Quidel has its manufacturing and research and development facilities in California and Ohio. The company offers its products to physicians, hospitals, clinical laboratories, retail clinics and wellness screening centers. Quidel distributes its products through its direct sales force and also through a network of national and regional distributors. The company has a presence in the US and Germany through its offices and subsidiaries. Quidel is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Quidel Corporation
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Methodology

Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.

The data is gathered from a wide range of sources, including industry reports, government statistics, and company financials. This data is then analyzed and cross-referenced to ensure its accuracy and reliability. Next, primary interviews are conducted with industry experts and key stakeholders to gather their insights and perspectives on the market. This information is then combined with the data collected to provide a complete picture of the market. Macro-economic factor analysis is also carried out to understand the impact of external factors on the market. Finally, country-level data analysis is performed to understand the market dynamics in specific regions and countries.

Reportlinker's market research methodology is designed to provide clients with a clear understanding of the market, its trends, and its future potential.

Related Topics

• Infectious Disease
• Antibiotic Resistance
• Life Sciences
• Healthcare
• Pathology

Related Reports

• MRSA Drugs Market by MRSA Type, Drug Class, Disease Indication, Route of Administration, Distribution Channel, and Region 2023-2028
  $ 2499

  February 2023 147 pages

• Global Antimicrobial Resistance Diagnostics Market Size, Share & Industry Trends Analysis Report By Technology, By End User, By Pathogen, By Regional Outlook and Forecast, 2022 - 2028
  $ 3600

  November 2022 288 pages

• Hospital Acquired Infections Testing Kits Global Market Report 2023
  $ 5000

  February 2023 250 pages

More Reports

• Infectious Disease - Scandinavia
• Infectious Disease - France
• Infectious Disease - Baltics
• Infectious Disease - Italy
• Infectious Disease - Poland
• Infectious Disease - Spain
• Infectious Disease - Serbia
• Infectious Disease - United Kingdom
• Infectious Disease - Romania
• Infectious Disease - Germany